Use of the Dermatology Life Quality Index suite of patient-reported outcome measures in skin-related neglected tropical diseases

被引：0

作者：

Junejo, Muhammad H.

Wolfe, Isabella

Patel, Jaina

Duus, Emma

Oyebanji, Oluwatobiloba

Walker, Stephen L.

机构：

[1] Department of Dermatology, The Royal London Hospital, London

[2] Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London

[3] Department of Dermatology, University College London Hospitals Nhs Foundation Trust, London

[4] Hospital for Tropical Diseases, University College London Hospitals Nhs Foundation Trust, London

[5] Faculty of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, London

来源：

BRITISH JOURNAL OF DERMATOLOGY | 2023年 / 189卷 / 04期

关键词：

D O I：

10.1093/bjd/ljad217

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

Skin-related neglected tropical diseases (NTDs) affect nearly 1 billion people worldwide, contributing to significant physical and psychological morbidity. The DLQI suite of patient-reported outcome measures is widely used to assess the impact of skin diseases on individuals' health-related quality of life (HRQoL), but it has not been validated for use in skin-related NTDs. The new strategic framework for the control of skin-related NTDs identified the socioeconomic and mental health impact of skin NTDs as research gaps to be addressed. Robust assessments of HRQoL will be an essential part of this research and will require validated appropriate tools, including the DLQI.

引用

页码：490 / 492

页数：3

共 50 条

[31] Quality of life in persons with voice disorders: A review of patient-reported outcome measures
Slavych, Bonnie
Engelhoven, Amy
Zraick, Richard
INTERNATIONAL JOURNAL OF THERAPY AND REHABILITATION, 2013, 20 (06): : 308 - 315
[32] A perspective on the use of patient-reported experience and patient-reported outcome measures in ambulatory healthcare
Hays, Ron D.
Quigley, Denise D.
EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH, 2025,
[33] Patient-Reported Impact of Dermatological Diseases (PRIDD) is a new patient-reported outcome measure for dermatology: why is it needed?
Howells, Laura
BRITISH JOURNAL OF DERMATOLOGY, 2024, 191 (02) : e4 - e4
[34] Selecting patient-reported outcome measures of health-related quality of life in adult rheumatology: quality and breadth of coverage
Erin Knight
Karen E. Schifferdecker
Guy S. Eakin
Bryce B. Reeve
Rheumatology International, 2023, 43 : 627 - 638
[35] Selecting patient-reported outcome measures of health-related quality of life in adult rheumatology: quality and breadth of coverage
Knight, Erin
Schifferdecker, Karen E.
Eakin, Guy S.
Reeve, Bryce B.
RHEUMATOLOGY INTERNATIONAL, 2023, 43 (04) : 627 - 638
[36] Quality of life assessment using patient-reported outcome (PRO) measures: still a Cinderella outcome?
Fallowfield, L. J.
ANNALS OF ONCOLOGY, 2018, 29 (12) : 2286 - 2287
[37] Patient-Reported Outcome Measures in Neuromuscular Diseases: A Scoping Review
Voet, Nicoline
Pater, Ronne
Garmendia, Joana
Sistiaga, Andone
Labayru, Garazi
Gallais, Benjamin
de Groot, Ingrid
Muslemani, Samar
Gagnon, Cynthia
Graham, Christopher
JOURNAL OF NEUROMUSCULAR DISEASES, 2024, 11 (03) : 567 - 577
[38] Utility of patient-reported outcome measures in nonmelanoma skin cancers
Wali, G.
Gibbons, E.
Mackenzie, T.
Perkins, W.
Reed, J.
Turner, R.
Matin, R.
BRITISH JOURNAL OF DERMATOLOGY, 2016, 175 : 211 - 211
[39] Exploring patient reported quality of life in lung cancer patients: A qualitative study of patient-reported outcome measures
Jensen-Marini, Elena
Ayton, Darshini
Zalcberg, John
Stirling, Robert G.
ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2025, 21 (02) : 163 - 173
[40] The Use of Patient-Reported Outcome Measures in Rare Diseases and Implications for Health Technology Assessment
Whittal, Amanda
Meregaglia, Michela
Nicod, Elena
PATIENT-PATIENT CENTERED OUTCOMES RESEARCH, 2021, 14 (05): : 485 - 503

← 1 2 3 4 5 →